Yasuyuki Kawamoto, Hiromichi Nakajima, Yoshito Komatsu, Hitomi Kubota, Kazuko Tsukamoto, Koji Takahashi, Keiko Kobayashi, Haruru Kotani, Fumikata Hara, Taigo Kato, Norio Nonomura, Takashi Ikeno, Masashi Wakabayashi, Akihiro Sato, Yoichi Naito. "A phase 1 study of PARP inhibitor (niraparib) plus HSP90 inhibitor (pimitespib) in solid tumors: Dose-expansion results from the NiraPim (EPOC2102) study.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.3079